Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles P Hart

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Pharmacology|April 14, 2019
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of EvofosfamideFrancis W Hunter, Jules B L Devaux, Fanying Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia ModelsJuliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
JCI Insight|August 24, 2018
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinomaStephen Mf Jamieson, Peter Tsai, Maria K Kondratyev, et al.
JCI Insight|February 22, 2023
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinomaStephen Mf Jamieson, Peter Tsai, Maria K Kondratyev, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Pharmacology|April 14, 2019
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of EvofosfamideFrancis W Hunter, Jules B L Devaux, Fanying Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia ModelsJuliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
JCI Insight|August 24, 2018
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinomaStephen Mf Jamieson, Peter Tsai, Maria K Kondratyev, et al.
JCI Insight|February 22, 2023
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinomaStephen Mf Jamieson, Peter Tsai, Maria K Kondratyev, et al.
Pageof 4